Kiran Kaur Khush, MD
Cardiovascular Disease (Cardiology) · Stanford
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 17
- 3 carriers
- Offices
- 3
Offices
3 locations · Stanford Health Care · 3,152 clinicians in this group
Hospitals listed: El Camino Health · Stanford Health Care · Stanford Health Care Tri-Valley. That is not proof they admit you there this week.
Plans that list them
17 plans · 3 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Khush’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
17 of 17 plans
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| SCAN Balance (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Classic (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN MyChoice (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
California Medical Board record
Licence A76368 · Current
Licensed to practise in California · since 2001 · expires 2027-07-31 · Harvard Medical School.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
3 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- El Camino HealthMountain View, CAAcute Care Hospital · Government - Hospital District or Authority · Has an emergency department · Birthing-friendlyPart of El Camino Health, which runs 2 hospitalsPatients rate it 4 of 5 · 80% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.291, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.393, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0, Oct 2024 – Sep 2025
- Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend itOverall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
- Stanford Health Care Tri-ValleyPleasanton, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Stanford Health Care, which runs 3 hospitalsPatients rate it 3 of 5 · 74% would definitely recommend itOverall rating: 5 of 5 starsBetter than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.178, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.237, Oct 2024 – Sep 2025
See every measure and the patient survey for El Camino Health
Behind the star rating — Deaths: 3 better, 5 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 1 better, 9 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.291 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.393 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.96 (0.12 to 1.79) · 2,340 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.02 (0.76 to 1.28) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 167.38 (125.03 to 209.73) · 96 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.6 · 68 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.1 · 185 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.8 · 200 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.9 · 814 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13 · 842 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.6 · 361 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.6 · 4,633 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.16 (0 to 0.34) · 11,474 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.27 (0.1 to 0.45) · 11,626 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.14 (1.39 to 4.9) · 2,814 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 2 (0.61 to 3.39) · 1,327 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.8 to 3.43) · 2,641 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 9.39 (4.18 to 14.6) · 1,287 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 6.57 (3.47 to 9.68) · 1,308 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 2.14 (0.71 to 3.57) · 827 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.6 (0.05 to 1.15) · 9,460 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.5 · 122 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.993 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.706 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.376 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.5 · 218 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.5 · 962 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 3.8 · 200 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -17 · 922 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 18.6 · 860 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.7 · 827 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 6.1 (4.5 to 8.2) · 313 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 13.4 (10.6 to 16.5) · 313 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.1 · 144 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.3 · 80 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.7 · 237 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.8 (10 to 16.1) · 1,639 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.8 to 1.1) · 1,619 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,535 patients answered, 22% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 79% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 61% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 86% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 76% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 75% |
| Nurses "always" listened carefully | 76% |
| Nurses "always" treated them with courtesy and respect | 87% |
| "Always" quiet at night | 47% |
| "YES", patients would definitely recommend the hospital | 80% |
| Staff "always" explained possible side effects | 46% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
See every measure and the patient survey for Stanford Health Care
Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 5.31 (4.24 to 6.37) · 8,661 cases | Worse | Jul 2022 – Jun 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 14.1 (12.7 to 15.7) · 2,191 cases | Worse | Jan 2024 – Dec 2024 |
| Postoperative respiratory failure rateComplications and deaths | 4.08 (1.95 to 6.21) · 5,296 cases | Better | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.317 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.446 | Better | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.241 | Better | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.7 (0.6 to 0.9) · 3,348 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.06 (0.45 to 1.67) · 5,374 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.86 (0.72 to 1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 166.09 (137.88 to 194.3) · 470 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.1 · 192 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.4 · 146 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.7 · 253 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 6.3 · 880 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 935 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.7 · 501 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.1 · 7,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.13 (0 to 0.27) · 20,799 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.14 to 0.43) · 23,182 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 0.94 (0.2 to 1.68) · 5,694 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.36 (1.54 to 3.19) · 7,846 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.2 (3.76 to 6.64) · 5,603 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.38 (0.23 to 2.53) · 2,211 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.52 (0.21 to 0.83) · 19,915 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.6 · 416 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.869 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.857 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.368 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16.2 · 247 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.5 · 1,021 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 47.8 · 258 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -1.6 · 990 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 20.8 · 976 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.5 · 959 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (4.4 to 6.2) · 2,191 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 425 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.6 · 158 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 183 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.7 (10.4 to 15.4) · 4,578 cases | No different | Jan 2022 – Dec 2024 |
What patients said (6,810 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 82% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 79% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 83% |
| Staff "always" explained possible side effects | 50% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
See every measure and the patient survey for Stanford Health Care Tri-Valley
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 2 better, 7 the same, 0 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.178 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.237 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.79 (0 to 1.73) · 1,041 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.79 (0.5 to 1.08) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 145.81 (96.5 to 195.12) · 72 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.9 · 55 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 8.6 · 92 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12.5 · 96 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.5 · 395 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 391 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.1 · 162 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3 · 1,736 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.16 (0 to 0.37) · 4,425 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.22 (0.02 to 0.41) · 4,771 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.45 (1.46 to 5.44) · 1,403 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.5 (0.05 to 2.94) · 645 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 1.81 (0.38 to 3.24) · 1,279 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 8.53 (3.2 to 13.85) · 639 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.15 (1.89 to 8.41) · 648 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.61 (0.14 to 3.07) · 370 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.16 (0 to 0.83) · 4,160 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4 · 74 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.369 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 1.112 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 13.1 · 110 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.1 · 437 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -5.8 · 94 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -19.3 · 456 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -0.3 · 402 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 15.8 · 358 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 6.8 (4.7 to 9.6) · 198 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 10.1 (7.5 to 13.6) · 198 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.3 · 80 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.9 · 46 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.3 · 92 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.4 (9.6 to 16.2) · 1,532 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.8 to 1.2) · 929 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,268 patients answered, 26% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 65% |
| Nurses "always" communicated well | 77% |
| Doctors "always" communicated well | 79% |
| Staff "always" explained | 58% |
| Yes, staff "did" give patients this information | 88% |
| Yes, staff "did" give patients information about help after discharge | 88% |
| Doctors "always" explained things so they could understand | 74% |
| Doctors "always" listened carefully | 78% |
| Doctors "always" treated them with courtesy and respect | 86% |
| Patients who gave a rating of "9" or "10" (high) | 70% |
| Staff "always" explained new medications | 72% |
| Nurses "always" explained things so they could understand | 73% |
| Nurses "always" listened carefully | 74% |
| Nurses "always" treated them with courtesy and respect | 84% |
| "Always" quiet at night | 42% |
| "YES", patients would definitely recommend the hospital | 74% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 89% |
Original Medicare doctor bills
$59,551
Medicare paid this office $59,551 for 754 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 34 | $14,273 | $71 |
| Long return visit (40+ min) | 83 | $10,736 | $114 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 19 | $7,237 | $106 |
| Long return visit (40+ min) | 28 | $4,964 | $165 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 463 | $3,696 | $7 |
See all 12 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 34 | $14,273 | $71 |
| Long return visit (40+ min) | 83 | $10,736 | $114 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 19 | $7,237 | $106 |
| Long return visit (40+ min) | 28 | $4,964 | $165 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 463 | $3,696 | $7 |
| Return visit (30+ min) | 38 | $2,942 | $77 |
| Return visit (30+ min) | 26 | $2,895 | $111 |
| New patient visit (60+ min) | 17 | $2,776 | $163 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 13 | $1,998 | $154 |
| Heart rhythm review and interpretation of continous external ekg over 8-15 days | 82 | $1,818 | $22 |
| Hospital discharge day management, 30 minutes or less | 15 | $1,114 | $74 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 11 | $153 | $14 |
Who their Medicare patients are
754 Original Medicare patients in 2024. Average age 73 · Under 65 14% · 85 and older 13% · Women 48% · Also on Medicaid 35% · Health risk score 2.40. Above the middle of the specialty; the typical cardiology clinician is at 1.71.
Conditions among them: High blood pressure 75% · Coronary heart disease 48% · Chronic kidney disease 46% · Atrial fibrillation 45% · Heart failure 44% · Diabetes 42% · Depression 25% · Cancer 20% · COPD 20% · Dementia 18% · Stroke 18%.
The office billed $272,158, Medicare allowed $77,741 and paid $59,551; for 1,257 services of 18 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 754 | 1,257 | 73 | 2.40 | $272,158 | $59,551 |
| 2023 | 298 | 995 | 71 | 2.89 | $283,942 | $73,414 |
| 2022 | 602 | 1,192 | 72 | 2.42 | $265,861 | $64,848 |
| 2021 | 578 | 1,133 | 71 | 2.67 | $245,356 | $60,265 |
| 2020 | 486 | 986 | 71 | 2.58 | $216,989 | $48,857 |
| 2019 | 662 | 1,118 | 72 | 2.66 | $255,051 | $51,609 |
| 2018 | 461 | 881 | 70 | 2.52 | $257,214 | $52,726 |
| 2017 | 614 | 1,083 | 71 | 2.51 | $243,049 | $53,015 |
| 2016 | 342 | 697 | 69 | 2.35 | $162,871 | $39,675 |
| 2015 | 151 | 497 | 67 | 2.82 | $146,808 | $41,295 |
| 2014 | 117 | 385 | 65 | 2.57 | $84,284 | $25,411 |
| 2013 | 83 | 169 | 66 | 2.23 | $32,669 | $9,880 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 9 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 51 | $22,326 | $73 |
| Long return visit (40+ min) | 112 | $17,182 | $119 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 23 | $13,932 | $110 |
| Evaluation of lower heart chamber assist device | 21 | $5,841 | $36 |
| Return visit (30+ min) | 60 | $4,983 | $77 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 14 | $2,879 | $160 |
| Hospital discharge day management, 30 minutes or less | 24 | $2,050 | $76 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 75 | $643 | $7 |
| Heart rhythm review and interpretation of continous external ekg over 8-15 days | 21 | $503 | $24 |
2022: 9 services
| Long return visit (40+ min) | 113 | $17,567 | $116 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 48 | $15,411 | $65 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 26 | $10,413 | $93 |
| Return visit (30+ min) | 59 | $4,308 | $65 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 17 | $4,000 | $182 |
| Evaluation of lower heart chamber assist device | 13 | $2,879 | $36 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 343 | $2,865 | $7 |
| Hospital discharge day management, 30 minutes or less | 18 | $1,480 | $67 |
| Heart rhythm review and interpretation of continous external ekg over 8-15 days | 48 | $1,144 | $23 |
2021: 10 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 38 | $14,954 | $66 |
| Long return visit (40+ min) | 88 | $13,172 | $125 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 26 | $9,832 | $95 |
| Return visit (30+ min) | 101 | $9,169 | $76 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 337 | $2,848 | $7 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 11 | $2,267 | $189 |
| Evaluation of lower heart chamber assist device | 13 | $1,891 | $35 |
| New patient visit (45+ min) | 12 | $1,179 | $98 |
| Hospital discharge day management, 30 minutes or less | 11 | $883 | $68 |
| Heart rhythm review and interpretation of continous external ekg over 8-15 days | 41 | $883 | $22 |
2020: 9 services
| Return visit (30+ min) | 121 | $12,004 | $67 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 30 | $8,729 | $66 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 23 | $8,407 | $97 |
| Evaluation of lower heart chamber assist device | 19 | $5,084 | $43 |
| Long return visit (40+ min) | 44 | $4,952 | $97 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 267 | $2,285 | $8 |
| Review and interpretation of external ekg recording for more than 48 hours up to 21 days | 45 | $1,149 | $24 |
| Return visit (30+ min) | 14 | $1,009 | $72 |
| Hospital discharge day management, 30 minutes or less | 12 | $825 | $69 |
2019: 7 services
| Long return visit (40+ min) | 95 | $13,670 | $98 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 35 | $13,489 | $94 |
| Return visit (30+ min) | 72 | $6,786 | $66 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 23 | $4,885 | $66 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 460 | $3,759 | $7 |
| Hospital discharge day management, 30 minutes or less | 16 | $1,216 | $68 |
| Review and interpretation of external ekg recording for more than 48 hours up to 21 days | 22 | $539 | $25 |
2018: 9 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 36 | $22,001 | $94 |
| Long return visit (40+ min) | 91 | $11,387 | $96 |
| Return visit (30+ min) | 55 | $5,153 | $64 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 20 | $3,595 | $65 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 12 | $2,547 | $182 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 281 | $2,307 | $8 |
| Hospital discharge day management, 30 minutes or less | 21 | $1,672 | $67 |
| New patient visit (45+ min) | 12 | $1,383 | $115 |
| Review and interpretation of external ekg recording for more than 48 hours up to 21 days | 14 | $343 | $25 |
2017: 9 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 38 | $21,781 | $93 |
| Long return visit (40+ min) | 87 | $11,436 | $97 |
| Return visit (30+ min) | 70 | $5,175 | $58 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 20 | $3,692 | $65 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 421 | $3,658 | $8 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 12 | $2,719 | $181 |
| New patient visit (45+ min) | 12 | $1,155 | $96 |
| Hospital discharge day management, 30 minutes or less | 15 | $994 | $66 |
| Review and interpretation of external ekg recording for more than 48 hours up to 21 days | 36 | $857 | $24 |
2016: 6 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 21 | $16,111 | $93 |
| Long return visit (40+ min) | 55 | $8,327 | $93 |
| Return visit (30+ min) | 61 | $5,121 | $63 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 14 | $2,701 | $64 |
| New patient visit (45+ min) | 18 | $1,925 | $107 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 202 | $1,875 | $8 |
2015: 6 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 22 | $13,856 | $92 |
| Long return visit (40+ min) | 61 | $9,938 | $99 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 18 | $6,087 | $65 |
| Return visit (30+ min) | 68 | $5,486 | $63 |
| New patient visit (60+ min) | 12 | $1,691 | $141 |
| New patient visit (30+ min) | 13 | $614 | $47 |
2014: 6 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 25 | $10,571 | $63 |
| Return visit (30+ min) | 82 | $9,167 | $67 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 12 | $1,461 | $122 |
| Short return visit (20+ min) | 21 | $1,183 | $42 |
| New patient visit (30+ min) | 16 | $1,080 | $68 |
| Hospital discharge day management, 30 minutes or less | 12 | $851 | $65 |
2013: 3 services
| Return visit (30+ min) | 47 | $4,170 | $65 |
| Short return visit (20+ min) | 30 | $1,534 | $38 |
| New patient visit (30+ min) | 16 | $1,054 | $66 |
Medicaid work
$2,849 in 2024
Medicaid paid $2,849 for 346 billed services this clinician did in 2024, up to 147 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 346 | $2,849 |
| 2024 | 346 | 1 | 147 | $2,849 |
| 2023 | 79 | 2 | 60 | $1,008 |
| 2022 | 374 | 2 | 119 | $3,979 |
| 2021 | 371 | 2 | 82 | $4,275 |
| 2020 | 288 | 2 | 68 | $3,720 |
| 2019 | 298 | 1 | 111 | $3,104 |
| 2018 | 122 | 1 | 38 | $1,482 |
See the largest Medicaid services in earlier years
2023
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 67 | $686 |
| Long return visit (40+ min) | 12 | $322 |
2022
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 361 | $3,786 |
| External electrocardiographic recording for more than 7 days up to 15 days by continuous rhythm recording and storage; review and interpretation | 13 | $193 |
2021
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 332 | $3,617 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 39 | $658 |
2020
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 263 | $3,129 |
| Return visit (30+ min) | 25 | $591 |
2019
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 298 | $3,104 |
2018
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 122 | $1,482 |
Drugs they prescribed that Part D paid
$391,250
Pharmacies billed $391,250 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
2,094 generic and 285 brand-name prescriptions · $391,250 in drug cost · 34 antibiotic prescriptions to 13 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Eliquis | 76 | $85,713 | $1,128 |
| Entresto | 38 | $48,983 | $1,289 |
| Xarelto | 28 | $40,216 | $1,436 |
| Jardiance | 36 | $37,920 | $1,053 |
| Everolimus | 54 | $34,530 | $639 |
See all 44 drugs
| Eliquis | 76 | $85,713 | $1,128 |
| Entresto | 38 | $48,983 | $1,289 |
| Xarelto | 28 | $40,216 | $1,436 |
| Jardiance | 36 | $37,920 | $1,053 |
| Everolimus | 54 | $34,530 | $639 |
| Farxiga | 29 | $32,883 | $1,134 |
| Repatha Sureclick | 16 | $14,098 | $881 |
| Sirolimus | 39 | $13,377 | $343 |
| Tacrolimus | 135 | $8,179 | $61 |
| Rosuvastatin | 243 | $5,372 | $22 |
| Diltiazem 24hr Er (Cd) | 51 | $2,587 | $51 |
| Mycophenolic Acid | 22 | $2,408 | $109 |
| Bumetanide | 55 | $2,300 | $42 |
| Mycophenolate Mofetil | 14 | $2,035 | $145 |
| Potassium Chloride | 76 | $1,649 | $22 |
| Ezetimibe | 53 | $1,548 | $29 |
| Losartan | 105 | $1,282 | $12 |
| Metoprolol | 74 | $1,142 | $15 |
| Pantoprazole | 74 | $1,027 | $14 |
| Atorvastatin | 95 | $990 | $10 |
| Carvedilol | 72 | $759 | $11 |
| Lisinopril | 87 | $556 | $6 |
| Amlodipine Besylate | 98 | $417 | $4 |
| Clopidogrel | 19 | $383 | $20 |
| Spironolactone | 49 | $334 | $7 |
| Furosemide | 62 | $324 | $5 |
| Chlorthalidone | 20 | $314 | $16 |
| Hydroxyzine | 15 | $295 | $20 |
| Mirtazapine | 38 | $292 | $8 |
| Famotidine | 55 | $274 | $5 |
| Flecainide Acetate | 12 | $269 | $22 |
| Isosorbide Mononitrate Er | 16 | $251 | $16 |
| Hydralazine | 24 | $250 | $10 |
| Levothyroxine | 24 | $237 | $10 |
| Gabapentin | 29 | $182 | $6 |
| Metoprolol | 27 | $163 | $6 |
| Warfarin | 22 | $154 | $7 |
| Tamsulosin | 23 | $125 | $5 |
| Allopurinol | 25 | $116 | $5 |
| Prednisone | 36 | $112 | $3 |
| Losartan-Hydrochlorothiazide | 14 | $80 | $6 |
| Metoclopramide | 12 | $44 | $4 |
| Sulfamethoxazole-Trimethoprim | 18 | $15 | $1 |
| Amoxicillin | 15 | $12 | $1 |
Year by year
| 2024 | 2,379 | 269 | None | 12% | $391,250 |
| 2023 | 2,349 | 262 | 0% (0) | None | $450,377 |
| 2022 | 2,208 | 256 | None | None | $333,678 |
| 2021 | 2,382 | 253 | 0% (0) | None | $311,504 |
| 2020 | 2,551 | 241 | None | 12% | $276,952 |
| 2019 | 2,654 | 226 | None | 12% | $307,429 |
| 2018 | 3,333 | 215 | None | 13% | $375,265 |
| 2017 | 3,178 | 217 | None | 15% | $340,418 |
| 2016 | 2,272 | 169 | None | 17% | $297,413 |
| 2015 | 1,717 | 147 | None | None | $325,019 |
| 2014 | 1,429 | 120 | None | 21% | $278,196 |
| 2013 | 1,077 | 110 | None | None | $108,775 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 50 drugs
| Eliquis | 60 | $71,226 | $1,187 |
| Xarelto | 39 | $50,207 | $1,287 |
| Entresto | 35 | $48,048 | $1,373 |
| Sirolimus | 63 | $37,377 | $593 |
| Farxiga | 30 | $36,854 | $1,228 |
| Jardiance | 22 | $24,660 | $1,121 |
| Envarsus Xr | 14 | $23,018 | $1,644 |
| Tacrolimus | 130 | $21,117 | $162 |
| Everolimus | 20 | $16,627 | $831 |
| Mycophenolic Acid | 24 | $16,062 | $669 |
| Valganciclovir | 36 | $9,158 | $254 |
| Rosuvastatin | 163 | $6,668 | $41 |
| Breo Ellipta | 11 | $4,733 | $430 |
| Atorvastatin | 131 | $3,157 | $24 |
| Bumetanide | 41 | $2,892 | $71 |
| Losartan | 111 | $2,814 | $25 |
| Ezetimibe | 50 | $2,641 | $53 |
| Mycophenolate Mofetil | 27 | $2,488 | $92 |
| Diltiazem 24hr Er (Cd) | 43 | $2,475 | $58 |
| Metoprolol | 74 | $2,280 | $31 |
| Carvedilol | 93 | $1,845 | $20 |
| Amlodipine Besylate | 108 | $1,552 | $14 |
| Potassium Chloride | 53 | $1,504 | $28 |
| Omega-3 Acid Ethyl Esters | 18 | $1,406 | $78 |
| Cyclosporine Modified | 12 | $1,405 | $117 |
| Lisinopril | 111 | $1,229 | $11 |
| Hydralazine | 42 | $891 | $21 |
| Spironolactone | 45 | $842 | $19 |
| Famotidine | 35 | $790 | $23 |
| Pantoprazole | 52 | $766 | $15 |
| Digoxin | 12 | $606 | $51 |
| Losartan-Hydrochlorothiazide | 12 | $482 | $40 |
| Isosorbide Mononitrate Er | 20 | $479 | $24 |
| Pravastatin | 20 | $466 | $23 |
| Tamsulosin | 22 | $429 | $20 |
| Furosemide | 47 | $416 | $9 |
| Warfarin | 22 | $406 | $18 |
| Flecainide Acetate | 13 | $305 | $23 |
| Levothyroxine | 22 | $293 | $13 |
| Metoprolol | 20 | $230 | $11 |
| Trazodone | 13 | $194 | $15 |
| Prednisone | 29 | $149 | $5 |
| Triamterene-Hydrochlorothiazid | 13 | $119 | $9 |
| Allopurinol | 21 | $107 | $5 |
| Metoclopramide | 12 | $106 | $9 |
| Simvastatin | 11 | $97 | $9 |
| Hydrochlorothiazide | 20 | $92 | $5 |
| Mirtazapine | 14 | $91 | $6 |
| Alendronate | 12 | $30 | $2 |
| Amoxicillin | 23 | $21 | $1 |
2022: 53 drugs
| Eliquis | 26 | $41,841 | $1,609 |
| Xarelto | 28 | $40,252 | $1,438 |
| Everolimus | 25 | $29,405 | $1,176 |
| Sirolimus | 52 | $26,964 | $519 |
| Entresto | 16 | $24,052 | $1,503 |
| Tacrolimus | 135 | $22,724 | $168 |
| Envarsus Xr | 16 | $17,414 | $1,088 |
| Jardiance | 17 | $15,280 | $899 |
| Valganciclovir | 19 | $13,739 | $723 |
| Mycophenolic Acid | 20 | $10,706 | $535 |
| Rosuvastatin | 139 | $6,135 | $44 |
| Vascepa | 11 | $5,709 | $519 |
| Eplerenone | 11 | $4,702 | $427 |
| Mycophenolate Mofetil | 36 | $4,355 | $121 |
| Bumetanide | 29 | $3,099 | $107 |
| Diltiazem 24hr Er (Cd) | 49 | $2,701 | $55 |
| Potassium Chloride | 57 | $2,682 | $47 |
| Atorvastatin | 110 | $1,911 | $17 |
| Ezetimibe | 31 | $1,673 | $54 |
| Metoprolol | 66 | $1,356 | $21 |
| Carvedilol | 79 | $1,340 | $17 |
| Lisinopril | 118 | $1,275 | $11 |
| Losartan | 76 | $1,237 | $16 |
| Digoxin | 18 | $1,019 | $57 |
| Hydralazine | 41 | $892 | $22 |
| Spironolactone | 61 | $820 | $13 |
| Losartan-Hydrochlorothiazide | 17 | $739 | $43 |
| Amlodipine Besylate | 116 | $727 | $6 |
| Furosemide | 69 | $607 | $9 |
| Pantoprazole | 40 | $580 | $14 |
| Omega-3 Acid Ethyl Esters | 15 | $535 | $36 |
| Levothyroxine | 42 | $516 | $12 |
| Pravastatin | 18 | $425 | $24 |
| Famotidine | 34 | $387 | $11 |
| Diltiazem 24hr Er | 12 | $354 | $29 |
| Acyclovir | 13 | $331 | $25 |
| Isosorbide Mononitrate Er | 19 | $314 | $17 |
| Metoprolol | 25 | $267 | $11 |
| Clonidine | 14 | $264 | $19 |
| Gabapentin | 22 | $249 | $11 |
| Mirtazapine | 13 | $229 | $18 |
| Clopidogrel | 14 | $218 | $16 |
| Tamsulosin | 19 | $178 | $9 |
| Prednisone | 26 | $173 | $7 |
| Hydrochlorothiazide | 25 | $137 | $5 |
| Triamterene-Hydrochlorothiazid | 12 | $121 | $10 |
| Sulfamethoxazole-Trimethoprim | 15 | $111 | $7 |
| Allopurinol | 21 | $108 | $5 |
| Trazodone | 16 | $97 | $6 |
| Ramipril | 12 | $65 | $5 |
| Metoclopramide | 13 | $48 | $4 |
| Alendronate | 13 | $43 | $3 |
| Amoxicillin | 13 | $11 | $1 |
2021: 58 drugs
| Xarelto | 38 | $43,768 | $1,152 |
| Envarsus Xr | 26 | $41,202 | $1,585 |
| Sirolimus | 68 | $31,216 | $459 |
| Eliquis | 25 | $29,608 | $1,184 |
| Tacrolimus | 100 | $22,519 | $225 |
| Entresto | 19 | $20,083 | $1,057 |
| Pradaxa | 14 | $12,152 | $868 |
| Everolimus | 12 | $8,128 | $677 |
| Repatha Sureclick | 12 | $6,742 | $562 |
| Rosuvastatin | 167 | $6,544 | $39 |
| Valganciclovir | 16 | $5,174 | $323 |
| Mycophenolic Acid | 16 | $4,578 | $286 |
| Diltiazem 24hr Er (Cd) | 71 | $3,509 | $49 |
| Febuxostat | 15 | $3,303 | $220 |
| Bumetanide | 21 | $2,383 | $113 |
| Atorvastatin | 121 | $2,144 | $18 |
| Pantoprazole | 80 | $1,911 | $24 |
| Flecainide Acetate | 16 | $1,679 | $105 |
| Ezetimibe | 37 | $1,651 | $45 |
| Potassium Chloride | 44 | $1,443 | $33 |
| Metoprolol | 60 | $1,379 | $23 |
| Losartan | 74 | $1,338 | $18 |
| Digoxin | 20 | $1,240 | $62 |
| Carvedilol | 85 | $1,115 | $13 |
| Omega-3 Acid Ethyl Esters | 14 | $1,050 | $75 |
| Mycophenolate Mofetil | 17 | $1,047 | $62 |
| Hydralazine | 31 | $971 | $31 |
| Spironolactone | 63 | $731 | $12 |
| Lisinopril | 119 | $691 | $6 |
| Amlodipine Besylate | 100 | $625 | $6 |
| Pravastatin | 32 | $582 | $18 |
| Furosemide | 73 | $550 | $8 |
| Acyclovir | 18 | $491 | $27 |
| Levothyroxine | 29 | $463 | $16 |
| Famotidine | 49 | $462 | $9 |
| Chlorthalidone | 12 | $347 | $29 |
| Nitroglycerin | 12 | $334 | $28 |
| Losartan-Hydrochlorothiazide | 14 | $304 | $22 |
| Isosorbide Mononitrate Er | 20 | $292 | $15 |
| Gabapentin | 44 | $286 | $6 |
| Prednisone | 27 | $269 | $10 |
| Metoprolol | 36 | $264 | $7 |
| Clopidogrel | 12 | $242 | $20 |
| Tamsulosin | 23 | $199 | $9 |
| Warfarin | 15 | $189 | $13 |
| Simvastatin | 15 | $183 | $12 |
| Clonidine | 14 | $178 | $13 |
| Sertraline | 18 | $148 | $8 |
| Allopurinol | 18 | $137 | $8 |
| Hydrochlorothiazide | 27 | $104 | $4 |
| Trazodone | 16 | $90 | $6 |
| Glipizide | 21 | $74 | $4 |
| Ramipril | 15 | $65 | $4 |
| Atenolol | 11 | $57 | $5 |
| Mirtazapine | 12 | $52 | $4 |
| Alendronate | 12 | $38 | $3 |
| Sulfamethoxazole-Trimethoprim | 13 | $27 | $2 |
| Amoxicillin | 17 | $16 | $1 |
2020: 60 drugs
| Xarelto | 32 | $39,491 | $1,234 |
| Eliquis | 22 | $19,603 | $891 |
| Tacrolimus | 112 | $18,939 | $169 |
| Zortress | 14 | $16,636 | $1,188 |
| Sirolimus | 56 | $16,615 | $297 |
| Entresto | 13 | $16,068 | $1,236 |
| Pradaxa | 19 | $14,060 | $740 |
| Mycophenolic Acid | 19 | $13,896 | $731 |
| Lyrica | 13 | $10,120 | $778 |
| Repatha Sureclick | 18 | $8,164 | $454 |
| Rosuvastatin | 106 | $5,361 | $51 |
| Valganciclovir | 14 | $5,186 | $370 |
| Vascepa | 13 | $4,550 | $350 |
| Envarsus Xr | 13 | $4,355 | $335 |
| Ezetimibe | 56 | $3,200 | $57 |
| Diltiazem 24hr Er (Cd) | 49 | $3,002 | $61 |
| Mycophenolate Mofetil | 36 | $2,799 | $78 |
| Cyclosporine Modified | 18 | $2,349 | $130 |
| Atorvastatin | 113 | $2,074 | $18 |
| Potassium Chloride | 50 | $1,876 | $38 |
| Losartan | 93 | $1,740 | $19 |
| Bumetanide | 17 | $1,381 | $81 |
| Digoxin | 30 | $1,259 | $42 |
| Hydralazine | 38 | $1,243 | $33 |
| Omega-3 Acid Ethyl Esters | 13 | $1,140 | $88 |
| Metoprolol | 65 | $1,096 | $17 |
| Carvedilol | 103 | $926 | $9 |
| Pantoprazole | 80 | $856 | $11 |
| Pravastatin | 66 | $823 | $12 |
| Lisinopril | 123 | $795 | $6 |
| Clotrimazole | 14 | $745 | $53 |
| Spironolactone | 64 | $701 | $11 |
| Gabapentin | 66 | $669 | $10 |
| Levothyroxine | 46 | $583 | $13 |
| Nystatin | 14 | $569 | $41 |
| Isosorbide Mononitrate Er | 21 | $546 | $26 |
| Famotidine | 61 | $541 | $9 |
| Amlodipine Besylate | 93 | $488 | $5 |
| Chlorthalidone | 17 | $481 | $28 |
| Furosemide | 65 | $463 | $7 |
| Acyclovir | 21 | $424 | $20 |
| Tamsulosin | 27 | $352 | $13 |
| Clopidogrel | 14 | $317 | $23 |
| Cartia Xt | 13 | $307 | $24 |
| Clonidine | 14 | $293 | $21 |
| Prednisone | 31 | $265 | $9 |
| Sertraline | 28 | $262 | $9 |
| Metoprolol | 35 | $241 | $7 |
| Warfarin | 11 | $205 | $19 |
| Allopurinol | 32 | $200 | $6 |
| Simvastatin | 17 | $178 | $10 |
| Nitroglycerin | 11 | $168 | $15 |
| Ramipril | 25 | $128 | $5 |
| Minoxidil | 14 | $116 | $8 |
| Sulfamethoxazole-Trimethoprim | 23 | $116 | $5 |
| Hydrochlorothiazide | 28 | $109 | $4 |
| Alendronate | 32 | $108 | $3 |
| Buspirone | 12 | $72 | $6 |
| Finasteride | 12 | $71 | $6 |
| Amoxicillin | 17 | $55 | $3 |
2019: 61 drugs
| Xarelto | 46 | $40,451 | $879 |
| Sirolimus | 57 | $33,015 | $579 |
| Eliquis | 36 | $22,544 | $626 |
| Repatha Sureclick | 17 | $20,565 | $1,210 |
| Mycophenolic Acid | 12 | $12,603 | $1,050 |
| Tacrolimus | 103 | $12,081 | $117 |
| Atovaquone | 12 | $11,249 | $937 |
| Valganciclovir | 21 | $10,241 | $488 |
| Pradaxa | 15 | $9,907 | $660 |
| Lyrica | 12 | $8,466 | $705 |
| Januvia | 12 | $5,768 | $481 |
| Mycophenolate Mofetil | 67 | $5,647 | $84 |
| Diltiazem 24hr Er (Cd) | 31 | $4,474 | $144 |
| Edarbyclor | 13 | $3,949 | $304 |
| Potassium Chloride | 79 | $3,665 | $46 |
| Rosuvastatin | 83 | $2,492 | $30 |
| Atorvastatin | 99 | $2,430 | $25 |
| Cyclosporine Modified | 28 | $2,238 | $80 |
| Omega-3 Acid Ethyl Esters | 19 | $1,874 | $99 |
| Pravastatin | 105 | $1,810 | $17 |
| Fluconazole | 13 | $1,801 | $139 |
| Ezetimibe | 38 | $1,643 | $43 |
| Levothyroxine | 79 | $1,168 | $15 |
| Lisinopril | 134 | $1,142 | $9 |
| Ultra-Fine Short Pen Needle | 12 | $1,067 | $89 |
| Losartan | 83 | $1,051 | $13 |
| Memantine | 11 | $1,046 | $95 |
| Metoprolol | 50 | $1,023 | $20 |
| Clotrimazole | 18 | $904 | $50 |
| Carvedilol | 90 | $856 | $10 |
| Hydralazine | 38 | $796 | $21 |
| Digoxin | 15 | $794 | $53 |
| Pantoprazole | 80 | $788 | $10 |
| Chlorthalidone | 26 | $785 | $30 |
| Diltiazem 24hr Er | 26 | $744 | $29 |
| Amlodipine Besylate | 72 | $722 | $10 |
| Acyclovir | 47 | $656 | $14 |
| Hydroxyzine | 21 | $635 | $30 |
| Bumetanide | 12 | $488 | $41 |
| Famotidine | 56 | $486 | $9 |
| Allopurinol | 41 | $484 | $12 |
| Furosemide | 74 | $482 | $7 |
| Gabapentin | 53 | $462 | $9 |
| Spironolactone | 44 | $451 | $10 |
| Isosorbide Mononitrate Er | 16 | $318 | $20 |
| Metoprolol | 34 | $301 | $9 |
| Clonidine | 11 | $296 | $27 |
| Prednisone | 43 | $293 | $7 |
| Clopidogrel | 11 | $245 | $22 |
| Ramipril | 26 | $231 | $9 |
| Alendronate | 33 | $218 | $7 |
| Simvastatin | 12 | $212 | $18 |
| Enalapril Maleate | 11 | $181 | $16 |
| Glipizide Er | 15 | $170 | $11 |
| Tamsulosin | 22 | $164 | $7 |
| Trazodone | 22 | $150 | $7 |
| Minoxidil | 11 | $133 | $12 |
| Sertraline | 26 | $107 | $4 |
| Buspirone | 12 | $92 | $8 |
| Sulfamethoxazole-Trimethoprim | 23 | $91 | $4 |
| Hydrochlorothiazide | 20 | $48 | $2 |
2018: 66 drugs
| Sirolimus | 87 | $37,983 | $437 |
| Tacrolimus | 167 | $18,588 | $111 |
| Xarelto | 21 | $17,531 | $835 |
| Lyrica | 24 | $16,286 | $679 |
| Mycophenolate Mofetil | 79 | $14,607 | $185 |
| Eliquis | 20 | $12,475 | $624 |
| Atovaquone | 12 | $12,392 | $1,033 |
| Valganciclovir | 13 | $9,199 | $708 |
| Pradaxa | 16 | $8,598 | $537 |
| Januvia | 19 | $8,578 | $451 |
| Epipen 2-Pak | 11 | $6,669 | $606 |
| Zetia | 13 | $4,474 | $344 |
| Uloric | 13 | $4,473 | $344 |
| Diltiazem 24hr Er (Cd) | 26 | $3,430 | $132 |
| Clotrimazole | 59 | $3,279 | $56 |
| Omega-3 Acid Ethyl Esters | 32 | $3,036 | $95 |
| Pravastatin | 190 | $2,869 | $15 |
| Potassium Chloride | 80 | $2,560 | $32 |
| Cyclosporine Modified | 21 | $1,883 | $90 |
| Levothyroxine | 117 | $1,779 | $15 |
| Atorvastatin | 76 | $1,696 | $22 |
| Hydralazine | 60 | $1,679 | $28 |
| Rosuvastatin | 76 | $1,633 | $21 |
| Ezetimibe | 25 | $1,623 | $65 |
| Gabapentin | 85 | $1,600 | $19 |
| Labetalol | 12 | $1,251 | $104 |
| Bumetanide | 31 | $1,234 | $40 |
| Lisinopril | 180 | $1,204 | $7 |
| Chlorthalidone | 33 | $1,089 | $33 |
| Doxycycline Hyclate | 11 | $979 | $89 |
| Digoxin | 19 | $868 | $46 |
| Carvedilol | 131 | $842 | $6 |
| Valsartan | 25 | $760 | $30 |
| Pantoprazole | 86 | $753 | $9 |
| Acyclovir | 38 | $723 | $19 |
| Furosemide | 118 | $686 | $6 |
| Isosorbide Mononitrate Er | 54 | $673 | $12 |
| Prednisone | 56 | $635 | $11 |
| Amlodipine Besylate | 129 | $615 | $5 |
| Clonidine | 31 | $573 | $18 |
| Losartan | 52 | $543 | $10 |
| Metoprolol | 26 | $531 | $20 |
| Triamcinolone Acetonide | 14 | $474 | $34 |
| Allopurinol | 57 | $469 | $8 |
| Famotidine | 66 | $447 | $7 |
| Spironolactone | 46 | $423 | $9 |
| Warfarin | 11 | $290 | $26 |
| Clopidogrel | 29 | $290 | $10 |
| Trazodone | 39 | $272 | $7 |
| Alendronate | 48 | $246 | $5 |
| Tamsulosin | 32 | $238 | $7 |
| Bupropion Xl | 12 | $232 | $19 |
| Glipizide Er | 21 | $227 | $11 |
| Metoprolol | 24 | $219 | $9 |
| Minoxidil | 14 | $175 | $13 |
| Ramipril | 24 | $153 | $6 |
| Glipizide Xl | 13 | $140 | $11 |
| Simvastatin | 11 | $136 | $12 |
| Mirtazapine | 14 | $124 | $9 |
| Omeprazole | 20 | $123 | $6 |
| Fluticasone Propionate | 16 | $119 | $7 |
| Sulfamethoxazole-Trimethoprim | 20 | $96 | $5 |
| Hydrochlorothiazide | 18 | $92 | $5 |
| Buspirone | 13 | $80 | $6 |
| Sertraline | 14 | $47 | $3 |
| Glipizide | 29 | $37 | $1 |
2017: 64 drugs
| Zortress | 35 | $75,610 | $2,160 |
| Sirolimus | 77 | $41,899 | $544 |
| Valganciclovir | 17 | $26,780 | $1,575 |
| Atovaquone | 18 | $16,451 | $914 |
| Tacrolimus | 136 | $16,012 | $118 |
| Creon | 11 | $13,293 | $1,208 |
| Xarelto | 11 | $9,621 | $875 |
| Mycophenolate Mofetil | 99 | $6,755 | $68 |
| Zetia | 17 | $6,491 | $382 |
| Novolog Flexpen | 12 | $6,302 | $525 |
| Sandimmune | 11 | $5,706 | $519 |
| Januvia | 12 | $4,658 | $388 |
| Pravastatin | 234 | $3,726 | $16 |
| Potassium Chloride | 98 | $2,644 | $27 |
| Clotrimazole | 44 | $2,553 | $58 |
| Ezetimibe | 15 | $2,478 | $165 |
| Diltiazem 24hr Er | 30 | $1,904 | $63 |
| Midodrine | 11 | $1,394 | $127 |
| Atorvastatin | 96 | $1,376 | $14 |
| Metoprolol | 57 | $1,138 | $20 |
| Prednisone | 59 | $1,124 | $19 |
| Levothyroxine | 68 | $1,117 | $16 |
| Hydralazine | 32 | $1,092 | $34 |
| Rosuvastatin | 31 | $1,034 | $33 |
| Chlorthalidone | 23 | $887 | $39 |
| Lisinopril | 137 | $881 | $6 |
| Bupropion Xl | 19 | $848 | $45 |
| Carvedilol | 123 | $842 | $7 |
| Cartia Xt | 31 | $808 | $26 |
| Gabapentin | 68 | $807 | $12 |
| Valsartan | 26 | $772 | $30 |
| Acyclovir | 44 | $762 | $17 |
| Bumetanide | 21 | $677 | $32 |
| Pen Needles | 20 | $636 | $32 |
| Pantoprazole | 63 | $603 | $10 |
| Amlodipine Besylate | 122 | $592 | $5 |
| Warfarin | 16 | $540 | $34 |
| Furosemide | 111 | $533 | $5 |
| Isosorbide Mononitrate Er | 32 | $511 | $16 |
| Clonidine | 39 | $498 | $13 |
| Nystatin | 12 | $486 | $41 |
| Tamsulosin | 21 | $462 | $22 |
| Allopurinol | 51 | $449 | $9 |
| Simvastatin | 21 | $369 | $18 |
| Diltiazem 24hr Cd | 17 | $364 | $21 |
| Clopidogrel | 31 | $351 | $11 |
| Losartan | 30 | $337 | $11 |
| Trazodone | 54 | $332 | $6 |
| Alendronate | 47 | $327 | $7 |
| Mirtazapine | 31 | $326 | $11 |
| Spironolactone | 44 | $311 | $7 |
| Insulin | 12 | $308 | $26 |
| Doxepin | 12 | $278 | $23 |
| Omeprazole | 17 | $213 | $13 |
| Sulfamethoxazole-Trimethoprim | 30 | $201 | $7 |
| Sertraline | 43 | $167 | $4 |
| Hydrochlorothiazide | 38 | $165 | $4 |
| Famotidine | 51 | $160 | $3 |
| Glipizide | 30 | $134 | $4 |
| Metoprolol | 28 | $111 | $4 |
| Ranitidine | 12 | $86 | $7 |
| Ramipril | 12 | $82 | $7 |
| Glipizide Xl | 11 | $72 | $7 |
| Dapsone | 11 | $22 | $2 |
2016: 57 drugs
| Atovaquone | 22 | $30,729 | $1,397 |
| Zortress | 21 | $25,746 | $1,226 |
| Sirolimus | 56 | $24,526 | $438 |
| Tacrolimus | 60 | $8,724 | $145 |
| Zetia | 23 | $6,348 | $276 |
| Sandimmune | 11 | $5,334 | $485 |
| Crestor | 14 | $5,315 | $380 |
| Lantus Solostar | 14 | $5,300 | $379 |
| Januvia | 13 | $4,773 | $367 |
| Clotrimazole | 52 | $3,914 | $75 |
| Mycophenolate Mofetil | 71 | $3,775 | $53 |
| Novolin 70-30 | 12 | $3,249 | $271 |
| Omega-3 Acid Ethyl Esters | 42 | $3,192 | $76 |
| Clonidine | 16 | $2,791 | $174 |
| Isosorbide Dinitrate | 16 | $2,481 | $155 |
| Potassium Chloride | 65 | $2,395 | $37 |
| Pravastatin | 117 | $2,122 | $18 |
| Atorvastatin | 64 | $1,238 | $19 |
| Metoprolol | 50 | $1,139 | $23 |
| Bumetanide | 22 | $904 | $41 |
| Hydralazine | 30 | $774 | $26 |
| Prednisone | 41 | $701 | $17 |
| Levothyroxine | 41 | $648 | $16 |
| Cartia Xt | 23 | $647 | $28 |
| Lisinopril | 82 | $640 | $8 |
| Diltiazem 24hr Er | 19 | $631 | $33 |
| Allopurinol | 60 | $510 | $8 |
| Flecainide Acetate | 13 | $491 | $38 |
| Mirtazapine | 30 | $463 | $15 |
| Nitrostat | 13 | $438 | $34 |
| Pantoprazole | 35 | $414 | $12 |
| Carvedilol | 74 | $411 | $6 |
| Sulfamethoxazole-Trimethoprim | 50 | $365 | $7 |
| Gabapentin | 26 | $350 | $13 |
| Simvastatin | 34 | $339 | $10 |
| Isosorbide Mononitrate Er | 20 | $333 | $17 |
| Amlodipine Besylate | 72 | $305 | $4 |
| Insulin | 11 | $281 | $26 |
| Baclofen | 13 | $279 | $21 |
| Clopidogrel | 23 | $278 | $12 |
| Lansoprazole | 12 | $272 | $23 |
| Warfarin | 22 | $266 | $12 |
| Famotidine | 55 | $261 | $5 |
| Furosemide | 66 | $219 | $3 |
| Zolpidem | 17 | $206 | $12 |
| Tamsulosin | 14 | $191 | $14 |
| Acyclovir | 13 | $184 | $14 |
| Alendronate | 35 | $183 | $5 |
| Metoprolol | 19 | $177 | $9 |
| Sertraline | 33 | $167 | $5 |
| Hydrochlorothiazide | 36 | $166 | $5 |
| Losartan | 22 | $162 | $7 |
| Diltiazem 24hr Cd | 13 | $158 | $12 |
| Valsartan | 12 | $156 | $13 |
| Trazodone | 41 | $130 | $3 |
| Clonidine | 17 | $126 | $7 |
| Glipizide | 19 | $121 | $6 |
2015: 44 drugs
| Noxafil | 12 | $68,185 | $5,682 |
| Zortress | 14 | $47,436 | $3,388 |
| Valganciclovir | 29 | $45,996 | $1,586 |
| Atovaquone | 27 | $37,531 | $1,390 |
| Rapamune | 14 | $9,231 | $659 |
| Tacrolimus | 39 | $8,506 | $218 |
| Sirolimus | 18 | $6,099 | $339 |
| Crestor | 25 | $5,139 | $206 |
| Nexium | 15 | $4,723 | $315 |
| Uloric | 12 | $3,099 | $258 |
| Mycophenolate Mofetil | 52 | $2,775 | $53 |
| Clotrimazole | 34 | $2,647 | $78 |
| Pravastatin | 119 | $2,427 | $20 |
| Bumetanide | 13 | $1,294 | $100 |
| Potassium Chloride | 33 | $1,292 | $39 |
| Hydralazine | 28 | $1,040 | $37 |
| Atorvastatin | 35 | $875 | $25 |
| Metoprolol | 21 | $861 | $41 |
| Levothyroxine | 32 | $858 | $27 |
| Carvedilol | 74 | $786 | $11 |
| Pantoprazole | 79 | $774 | $10 |
| Gabapentin | 27 | $510 | $19 |
| Lisinopril | 80 | $469 | $6 |
| Clopidogrel | 32 | $443 | $14 |
| Omeprazole | 28 | $432 | $15 |
| Sulfamethoxazole-Trimethoprim | 53 | $421 | $8 |
| Famotidine | 63 | $414 | $7 |
| Klor-Con 10 | 12 | $366 | $30 |
| Prednisone | 25 | $354 | $14 |
| Amlodipine Besylate | 58 | $340 | $6 |
| Isosorbide Mononitrate Er | 14 | $283 | $20 |
| Allopurinol | 18 | $231 | $13 |
| Bupropion Hcl Sr | 15 | $224 | $15 |
| Clonidine | 20 | $206 | $10 |
| Tamsulosin | 13 | $205 | $16 |
| Furosemide | 57 | $192 | $3 |
| Glipizide | 23 | $177 | $8 |
| Nitrostat | 11 | $163 | $15 |
| Losartan | 32 | $155 | $5 |
| Alendronate | 20 | $138 | $7 |
| Simvastatin | 19 | $137 | $7 |
| Hydrochlorothiazide | 18 | $125 | $7 |
| Metoprolol | 14 | $99 | $7 |
| Sertraline | 15 | $64 | $4 |
2014: 37 drugs
| Valcyte | 22 | $79,618 | $3,619 |
| Atovaquone | 23 | $37,813 | $1,644 |
| Tacrolimus | 49 | $12,366 | $252 |
| Rapamune | 19 | $10,553 | $555 |
| Crestor | 24 | $4,945 | $206 |
| Mycophenolate Mofetil | 38 | $3,518 | $93 |
| Avodart | 24 | $3,429 | $143 |
| Pravastatin | 115 | $2,531 | $22 |
| Clotrimazole | 28 | $1,558 | $56 |
| Potassium Chloride | 35 | $1,232 | $35 |
| Atorvastatin | 47 | $1,204 | $26 |
| Metoprolol | 22 | $940 | $43 |
| Diltiazem Er | 23 | $748 | $33 |
| Clopidogrel | 31 | $692 | $22 |
| Sulfamethoxazole-Trimethoprim | 76 | $686 | $9 |
| Carvedilol | 42 | $572 | $14 |
| Bumetanide | 12 | $529 | $44 |
| Prednisone | 33 | $501 | $15 |
| Pantoprazole | 49 | $489 | $10 |
| Lisinopril | 64 | $429 | $7 |
| Levothyroxine | 20 | $385 | $19 |
| Clonidine | 20 | $313 | $16 |
| Famotidine | 23 | $247 | $11 |
| Bupropion Hcl Sr | 21 | $232 | $11 |
| Omeprazole | 12 | $225 | $19 |
| Amlodipine Besylate | 33 | $203 | $6 |
| Warfarin | 16 | $194 | $12 |
| Gabapentin | 22 | $163 | $7 |
| Enalapril Maleate | 15 | $162 | $11 |
| Furosemide | 43 | $153 | $4 |
| Tamsulosin | 14 | $150 | $11 |
| Losartan | 18 | $110 | $6 |
| Zolpidem | 13 | $105 | $8 |
| Simvastatin | 12 | $102 | $8 |
| Allopurinol | 17 | $91 | $5 |
| Glipizide | 15 | $60 | $4 |
| Hydrochlorothiazide | 13 | $59 | $5 |
2013: 37 drugs
| Tacrolimus | 46 | $17,529 | $381 |
| Mepron | 12 | $15,304 | $1,275 |
| Januvia | 17 | $4,328 | $255 |
| Rapamune | 19 | $4,306 | $227 |
| Zetia | 16 | $4,051 | $253 |
| Humalog | 12 | $3,449 | $287 |
| Lovaza | 26 | $3,220 | $124 |
| Crestor | 17 | $3,185 | $187 |
| Mycophenolate Mofetil | 26 | $3,178 | $122 |
| Nexium | 12 | $2,610 | $217 |
| Avodart | 14 | $1,839 | $131 |
| Clotrimazole | 23 | $1,425 | $62 |
| Atorvastatin | 30 | $1,232 | $41 |
| Clonidine | 11 | $881 | $80 |
| Diltiazem 24hr Er | 19 | $876 | $46 |
| Metoprolol | 29 | $770 | $27 |
| Pravastatin | 52 | $704 | $14 |
| Carvedilol | 42 | $626 | $15 |
| Diltiazem Er | 13 | $614 | $47 |
| Sulfamethoxazole-Trimethoprim | 69 | $490 | $7 |
| Potassium Chloride | 17 | $443 | $26 |
| Tamsulosin | 33 | $439 | $13 |
| Pantoprazole | 22 | $363 | $16 |
| Lisinopril | 54 | $358 | $7 |
| Clonidine | 27 | $309 | $11 |
| Omeprazole | 17 | $252 | $15 |
| Alendronate | 16 | $249 | $16 |
| Amlodipine Besylate | 32 | $229 | $7 |
| Nizatidine | 12 | $195 | $16 |
| Furosemide | 31 | $154 | $5 |
| Prednisone | 15 | $150 | $10 |
| Simvastatin | 16 | $120 | $8 |
| Spironolactone | 11 | $84 | $8 |
| Losartan | 12 | $80 | $7 |
| Warfarin | 12 | $63 | $5 |
| Hydrochlorothiazide | 12 | $57 | $5 |
| Metoclopramide | 11 | $56 | $5 |
Money from drug and device companies
$9,640 in 2025
| 2025 | 1 | 2 | $9,640 | $9,640 |
| 2024 | 2 | 6 | None | $378 |
| 2023 | 1 | 1 | None | $74 |
| 2022 | 1 | 1 | None | $77 |
| 2021 | 1 | 1 | $4,572 | $4,572 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Sanofi-Aventis U.S. | None | $9,640 | 2 payments
|
See all 2 published payments
| Sanofi-Aventis U.S. | Consulting · 2025-01-24 | None | $4,820 |
| Sanofi-Aventis U.S. | Consulting · 2025-01-24 | None | $4,820 |
See earlier years (2024, 2023, 2022, 2021)
2024: $378
| Paragonix Technologies | Sherpapak | $332 | 5 payments
|
| Abiomed | Impella | $47 | 1 payment
|
2023: $74
| Abbott Laboratories | Thoratec Heartmate 3 Lvas Implant Kit | $74 | 1 payment
|
2022: $77
| XVIVO Perfusion | None | $77 | 1 payment
|
2021: $4,572
| Sanofi-Aventis U.S. | Thymoglobulin | $4,572 | 1 payment
|
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 76.5 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1386673457
- Licence
- CA A76368California A76368: Current · expires 2027-07-31
- Trained
- Harvard Medical School, 2000
- Group
- Stanford Health Care
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Medicaid ID
- CA 00A763680
- Taxonomy
- Federal specialty code 207RA0001X (207RA0001X); Cardiology (207RC0000X)
- Mailing address
- 300 Pasteur Dr, Stanford, CA, 94305
- NPI first listed
- 2006-07-01
- NPI last updated
- 2024-04-22
- NPI record certified
- 2024-04-22
This is when the NPI record was last certified, not a medical board exam.